Chemotherapy Drugs

PreclinicalSmall molecule

AARCAGY/ GINECO GROUP

Chemotherapy Drugs is one of 5 small molecule programs targeting IrAE. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IraeRecruiting

IraePreclinical

Recruiting

Competition

Competitive Landscape

4 competitors in Irae

#DrugCompanyPhaseTrials

Cosentyx

Novartis

Phase 1

1 2

Entyvio

Takeda

Preclinical

1 3

PD-1 and PD-L1 Inhibitor

TTianjin Medical University Cancer Institute and Hospital

Preclinical

1 4

Targeted Drugs

TTianjin Medical University Cancer Institute and Hospital

Preclinical

1 5

Chemotherapy Drugs

AARCAGY/ GINECO GROUP

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

N/ARecruiting

Irae

NCT06702566

Q1 2028

Post-ApprovalRecruiting

Pancreatic Cancer

NCT06368063

Q1 2029

PreclinicalRecruiting

Ovarian Carcinosarcoma

NCT03651206

Clinical

Trials by Indication[1]

IrAE1 trial

The Effect of Serum Ferritin in irAE

Recruiting·TTianjin Medical University Cancer Institute and Hospital·N/A·NCT06702566·1,500 enrolled

Ovarian Cancer1 trial

PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .

Completed·AARCAGY/ GINECO GROUP·Phase 2·NCT03275506·91 enrolled

Treatment1 trial

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Unknown status·SShenzhen Fifth People's Hospital·Phase 4·NCT03777930·200 enrolled

Pancreatic Cancer1 trial

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Recruiting·XXi'an Jiaotong University·Phase 4·NCT06368063·642 enrolled

Ovarian Carcinosarcoma1 trial

An International Multicentric Randomized Phase II Evaluating Dostarlimab in Combination With Niraparib Versus Niraparib Alone Compared to Chemotherapy in the Treatment of Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma After at Least One Line of Chemotherapy

Recruiting·AARCAGY/ GINECO GROUP·Preclinical·NCT03651206·138 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Chemotherapy Drugs. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chemotherapy Drugs compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chemotherapy Drugs. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — ARCAGY/ GINECO GROUP company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AARCAGY/ GINECO GROUP

Chemotherapy Drugs

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Q1 2028

Q1 2029

Trials by Indication[1]

IrAE1 trial

Ovarian Cancer1 trial

Treatment1 trial

Pancreatic Cancer1 trial

Ovarian Carcinosarcoma1 trial

References

Drug Info

Quick Facts

Related News